BioCentury | Jul 25, 2018
Distillery Therapeutics

Infectious disease

...R. et al. Sci. Signal. ; published online June 26, 2018 doi:10.1126/scisignal.aao2387 CONTACT: Min Wu, University of North Dakota...
...CONTACT: Jianxin Jiang, Third Military Medical University, Chongqing, Sichuan, China email: hellojjx@126.com Sandi Wong Third Military Medical University University of North Dakota School of Medicine MicroRNA-138...
BioCentury | Apr 5, 2017
Distillery Therapeutics

Neurology

...online March 22, 2017 doi:10.1523/JNEUROSCI.3010-16.2017 CONTACT: Brij B. Singh, University of North Dakota, Grand Forks, N.D. email: brij.singh@med.und.edu Hongjiang Li University of North Dakota School of Medicine Transient...
BioCentury | Sep 1, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-301b (miR-301b); interleukin-4 (IL-4) (BSF1); transforming growth factor β 1 (TGFβ1)

...Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China email: hcanhua@hotmail.com CONTACT: Min Wu, University of North Dakota...
BioCentury | Dec 7, 2015
Regulation

Talking the walk

...would take this 10-meter differential possibility," said Cheri Gunvalson, a clinical assistant professor at the University of North Dakota...
...Mass. University of California San Diego, La Jolla, Calif. University of Iowa, Iowa City, Iowa University of North Dakota...
BioCentury | Jul 30, 2012
Company News

Halo Healthcare, University of North Dakota School of Medicine deal

...technology. Details were not disclosed (see BioCentury, Jan. 16). Halo Healthcare Inc. , Irvine, Calif. University of North Dakota School of Medicine...
BioCentury | Jan 16, 2012
Company News

NeoMatrix, University of North Dakota School of Medicine deal

...can extend the option in mid-2012. Details were not disclosed. NeoMatrix LLC , Irvine, Calif. University of North Dakota School of Medicine...
Items per page:
1 - 6 of 6
BioCentury | Jul 25, 2018
Distillery Therapeutics

Infectious disease

...R. et al. Sci. Signal. ; published online June 26, 2018 doi:10.1126/scisignal.aao2387 CONTACT: Min Wu, University of North Dakota...
...CONTACT: Jianxin Jiang, Third Military Medical University, Chongqing, Sichuan, China email: hellojjx@126.com Sandi Wong Third Military Medical University University of North Dakota School of Medicine MicroRNA-138...
BioCentury | Apr 5, 2017
Distillery Therapeutics

Neurology

...online March 22, 2017 doi:10.1523/JNEUROSCI.3010-16.2017 CONTACT: Brij B. Singh, University of North Dakota, Grand Forks, N.D. email: brij.singh@med.und.edu Hongjiang Li University of North Dakota School of Medicine Transient...
BioCentury | Sep 1, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-301b (miR-301b); interleukin-4 (IL-4) (BSF1); transforming growth factor β 1 (TGFβ1)

...Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China email: hcanhua@hotmail.com CONTACT: Min Wu, University of North Dakota...
BioCentury | Dec 7, 2015
Regulation

Talking the walk

...would take this 10-meter differential possibility," said Cheri Gunvalson, a clinical assistant professor at the University of North Dakota...
...Mass. University of California San Diego, La Jolla, Calif. University of Iowa, Iowa City, Iowa University of North Dakota...
BioCentury | Jul 30, 2012
Company News

Halo Healthcare, University of North Dakota School of Medicine deal

...technology. Details were not disclosed (see BioCentury, Jan. 16). Halo Healthcare Inc. , Irvine, Calif. University of North Dakota School of Medicine...
BioCentury | Jan 16, 2012
Company News

NeoMatrix, University of North Dakota School of Medicine deal

...can extend the option in mid-2012. Details were not disclosed. NeoMatrix LLC , Irvine, Calif. University of North Dakota School of Medicine...
Items per page:
1 - 6 of 6